Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Toledano Miranda Jayne Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 4 Toledano Miranda Jayne (Director) has filed a Form 4 on NEXGEL, INC.
Txns: Granted 15,000 options to buy @ $2.05, valued at $30.8k
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/06/2023 4 Toledano Miranda Jayne (CEO) has filed a Form 4 on Entera Bio Ltd.
Txns: Bought 30,000 shares @ $1.01, valued at $30.3k
09/09/2022 4 Toledano Miranda Jayne (CEO) has filed a Form 4 on Entera Bio Ltd.
Txns: Granted 500,000 options to buy @ $2.02, valued at $1M
Granted 600,000 options to buy @ $1.4, valued at $840k
07/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2022 4 Toledano Miranda Jayne (Director) has filed a Form 4 on Journey Medical Corp
Txns: Granted 30,000 shares @ $0
01/19/2022 4 Toledano Miranda Jayne (Director) has filed a Form 4 on Entera Bio Ltd.
Txns: Bought 6,800 shares @ $2.7899, valued at $19k
01/11/2022 4 Toledano Miranda Jayne (Director) has filed a Form 4 on Entera Bio Ltd.
Txns: Granted 35,852 options to buy @ $2.815, valued at $100.9k
Granted 107,557 options to buy @ $2.815, valued at $302.8k
01/11/2022 3 Toledano Miranda Jayne (Director) has filed a Form 3 on Entera Bio Ltd.
01/03/2022 4 Toledano Miranda Jayne (Director) has filed a Form 4 on NEXGEL, INC.
Txns: Bought 1,819 shares @ $5.49, valued at $10k
Granted 1,819 options to buy @ $5.5, valued at $10k
11/26/2021 3 Toledano Miranda Jayne (Director) has filed a Form 3 on Journey Medical Corp
09/15/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/29/2021 4 Toledano Miranda Jayne (Director) has filed a Form 4 on Compass Therapeutics, Inc.
Txns: Acquired 1,791,549 shares @ $0
Granted 50,000 options to buy @ $4.9, valued at $245k
06/29/2021 3 Toledano Miranda Jayne (Director) has filed a Form 3 on Compass Therapeutics, Inc.
10/05/2016 3 Toledano Miranda Jayne (EVP-Corporate Development) has filed a Form 3 on Sorrento Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy